849
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Two cases of lupus miliaris disseminatus faciei successfully treated with oral tofacitinib

&
Article: 2244616 | Received 28 May 2023, Accepted 31 Dec 2023, Published online: 21 Aug 2023

Figures & data

Figure 1. Clinical presentation of Patient 1. (a, c) Multiple erythematous and reddish papules on the patient’s face at baseline. (b, d) The lesions improved after oral tofacitinib treatment. (e) Routine pathology (hematoxylin eosin, original magnification ×20) showing caseating granulomas and lymphocytes infiltrating.

Figure 1. Clinical presentation of Patient 1. (a, c) Multiple erythematous and reddish papules on the patient’s face at baseline. (b, d) The lesions improved after oral tofacitinib treatment. (e) Routine pathology (hematoxylin eosin, original magnification ×20) showing caseating granulomas and lymphocytes infiltrating.

Figure 2. Clinical presentation of Patient 2. (a) Multiple erythematous papules on the central part of the patient’s face at baseline. (b) Nearly resolution of lesions after oral tofacitinib treatment. (c) Routin pathology (hematoxylin eosin, original magnification ×20) showing non-caseating granulomas and lymphocytes infiltrating.

Figure 2. Clinical presentation of Patient 2. (a) Multiple erythematous papules on the central part of the patient’s face at baseline. (b) Nearly resolution of lesions after oral tofacitinib treatment. (c) Routin pathology (hematoxylin eosin, original magnification ×20) showing non-caseating granulomas and lymphocytes infiltrating.

Data availability statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.